Gsa Capital Partners LLP Soligenix, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$0.87 - $1.58 $118,756 - $215,673	-136,502 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$1.31 - $2.35 $23,329 - $41,851	17,809 Added 15.0%	136,502 $209,000
Q4 2020 Feb 03, 2021	SELL	$1.26 - $2.75 $21,532 - $46,994	-17,089 Reduced 12.59%	118,693 $152,000
Q3 2020 Nov 06, 2020	BUY	$1.7 - $2.61 $211,367 - $324,511	124,334 Added 1086.08%	135,782 $243,000
Q2 2020 Aug 11, 2020	BUY	$1.36 - $2.26 $15,569 - $25,872	11,448 New	11,448 $24,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $146M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.